Why is Astrazeneca Phar falling/rising?

As of 11-Aug, Astrazeneca Pharma India Ltd's stock price is currently at 8,880.00, reflecting an increase of 137.0, or 1.57%. The stock has been gaining for the last two days, with a total return of 1.74% during this period. It has outperformed its sector by 0.66% today. Additionally, the stock's performance over the year shows a significant increase of 32.33%, while it has also generated a remarkable 184.66% return over the past three years. The company has demonstrated high management efficiency with a return on equity (ROE) of 19.06% and a low debt-to-equity ratio, which supports its positive outlook. However, there are concerns regarding its long-term growth, as operating profit has only grown at an annual rate of 15.95% over the last five years, and the stock is trading at a premium compared to its peers.
In the broader market context, Astrazeneca's recent performance contrasts with the benchmark Sensex, which has seen a decline of 0.51% over the past week and 2.30% over the past month. While Astrazeneca's short-term returns have been positive, the stock's performance over the last month shows a decline of 3.86%, indicating some volatility. Despite this, the stock's year-to-date performance of 21.07% significantly outpaces the Sensex's 3.15%, highlighting its resilience in a challenging market environment. Overall, the combination of strong recent performance, efficient management, and positive financial results contributes to the stock's upward movement, despite some underlying risks.